CHI's Immuno-Oncology Summit is the leading annual meeting for the next wave of biotherapeutics, advances in technologies, and the exchange of high-quality research from all disciplines of immuno-oncology. With an international mix of thought leaders and decision makers from industry and academia, the Summit provides access to a comprehensive 3-day program to evaluate bi- or multi-specific biotherapeutics, explore the latest developments in existing and emerging cellular therapies, develop predictive preclinical models for translational strategies and appraise AI and computational tools for the discovery of new targets, target classes, and combinations to overcome resistance.

The Summit also offers extensive networking and collaborative opportunities to enable teams to focus on their goals as they advance our understanding of the immune system to provide next generation immunotherapies to all patients. Located in the Seaport Hotel in Boston, MA, the Summit provides a progressive venue to come together as a formidable force against cancer.

Join us at CHI's Immuno-Oncology Summit to stay up-to-date on the latest developments in immuno-oncology and to collaborate with industry and academic leaders to advance our understanding of the immune system and provide next generation immunotherapies to all patients.